Insider Stock Trading History of Campanelli Paul


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Campanelli Paul since year 2005. The trader's CIK number is 1392459. At the time of this reporting, Campanelli Paul is the President, CEO of Endo International Plc . (stock ticker symbol ENDP). See this page for all insider trading activities at Endo International Plc .

Note that in the past Campanelli Paul also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Campanelli Paul since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-14 ENDP Endo International Plc Buy 6,500 7.71 50,115
2017-03-16 ENDP Endo International Plc Buy 2,300 10.72 24,656
2016-05-10 ENDP Endo International Plc Buy 13,000 15.53 201,890
2015-11-11 ENDP Endo International Plc Buy 2,100 56.00 117,600
2011-03-07 PRX Par Pharmaceutical Companies, Inc. Option Ex 116,335 20.96 2,438,846
2011-03-07 PRX Par Pharmaceutical Companies, Inc. Sale 105,647 30.79 3,252,976
2011-03-07 PRX Par Pharmaceutical Companies, Inc. Sale 10,718 31.06 332,901
2011-03-08 PRX Par Pharmaceutical Companies, Inc. Sale 4,350 30.48 132,566
2011-03-08 PRX Par Pharmaceutical Companies, Inc. Sale 47,720 30.68 1,464,192
2010-03-02 PRX Par Pharmaceutical Companies, Inc. Option Ex 24,885 13.06 324,998
2010-03-02 PRX Par Pharmaceutical Companies, Inc. Sale 24,885 25.07 623,742
2009-08-24 PRX Par Pharmaceutical Companies, Inc. Sale 31,234 20.28 633,425
2007-10-03 PRX Par Pharmaceutical Companies, Inc. Buy 2,100 18.19 38,199

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Campanelli Paul (President, CEO of Endo International Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.